VCEL

#1768
Vericel Corporation - Common Stock
33.3 3 USD
-2.66%
부문: 헬스케어
베이스: USD
수익 통화: USD
일일 변동 비율
33.33
33.33
년간 변동
0.34
43.00
일일 변동
-2.66%
월간 변동
-0.30%
6달 변화
-16.21%
년간 변동율
-8.31%
이전 종가
34.2 4
Open
33.3 3
저가
33.3 3
High
33.3 3
양
114
전체 차트 열기 Full chart

Financials

개요 성명 통계
4분기 연간
  • Market Capitalization 1.7 B
  • Employee 398
  • Founded 1989
  • CEO Nick Colangelo
  • Website www.vcel.com
  • Headquarter Michigan, United States
  • FIGI BBG000BDCM24
  • Industry 생명공학
총매출
순이익
주당 순이익(기본 EPS)
총부채
잉여 현금 흐름
현금 및 현금성 자산
주가수익비율
112.53
주가매출액비율
6.8

Vericel Corporation - Common Stock

Vericel Corporation is a publicly traded American biopharmaceutical company which was known prior to October 2014 as Aastrom Bio. Aastrom Bio was formed in 1989 in Ann Arbor, Michigan. In the spring of 2014, Aastrom Bio acquired Sanofi's cell therapy and regenerative medicine business which Sanofi had acquired when purchasing Genzyme in 2011. This transformed Aastrom in several ways: it increased the employee count by 8-fold and provided a revenue stream and products to market, which it had not had before. In October 2014, the company changed its name from Aastrom Bio to Vericel and relocated its headquarters from Ann Arbor, Michigan to Cambridge, Massachusetts.

뉴스